Apple Inc. is delving into 3D printing technology, eyeing its potential for the production of the Apple Watch 9's stainless steel chassis. If successful, this innovative approach could revolutionize Apple's manufacturing process, speeding up production and reducing material waste. As sources suggest, this move has been three years in the making and could set a precedent for future Apple products, reshaping the tech giant's supply chain dynamics.
To be more exact, Apple plans to use 3D printers to make its smartwatch product's stainless steel chassis case. If this initial testing yields good results, the company is expected to proceed and launch mass production for Apple Watch's frame.
According to CNBC, the company has plans to further incorporate 3D printing into the manufacturing process of other products in the coming years. With the application of the 3D printing method, Apple can reduce the time required to make the Apple Watch and other devices.
The company is making the smartwatch chassis by cutting metal slabs and molding them according to the watch's shape. With 3D printers, the amount of materials needed in production will also be reduced.
Reuters reported that 3D printing could become a major part of Apple's supply chain if the trial succeeds. The process may also be used for other products, but the shift to this technology is not in the plans until 2024.
The shift will allow Apple to maximize its time for manufacturing its products while also saving big on materials. At any rate, Bloomberg further reported that Apple has been developing the 3D printing technique for at least three years now, and the trial run will show if the company may use it for its business and eventually change how Apple makes its products.
Photo by: Chris Karnbach/Unsplash


Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Samsung, SK Hynix Shares Plunge as China Chip Competition Grows
Bank of America Predicts Yen Rebound as USD/JPY Faces Risks
Most Americans Oppose Election Betting on Prediction Markets, Poll Finds
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
HUTCHMED, AstraZeneca Seek FDA Approval for Lung Cancer Combo
FDA Approves Mirum’s Atebrioz for Rare Bone Disorder FOP
Apple Cuts iPhone 18 Pro Production Orders Amid Weak Demand
Arthur Hayes Announces FLOP Testnet Launch Within Weeks
Elon Musk Accuses Indian Telecom Giants of Blocking Starlink Launch
Moonshot AI Executives Seek Settlement Ahead of Hong Kong IPO
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
The Beauty Beneath the Expressway: A Journey from Self to Service
Amazon Cuts More Jobs as AI Investment Expands
US Stock Futures Rise as Oil Prices Fall Ahead of Q3 Earnings 



